HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats
- 1 January 1998
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 16 (5) , 863-873
- https://doi.org/10.1016/s0731-7085(97)00128-3
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonistMedicinal Research Reviews, 1992
- Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studiesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- Large conduit arteries in hypertension: role of the vascular renin-angiotensin system.Circulation, 1988